Comparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.

NCT02198443 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: Tenofovir + emtricitabine (Truvada),+lopinavir/ritonavir (Kaletra)
DRUG: elvitegravir/cobicistat/emtricitabine/Tenofovir-Disoproxil

Sponsor

Fundacion Clinic per a la Recerca Biomédica